Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 24

Sort by

Sort Order Select

Journal Articles

Deferiprone Versus Deferoxamine in Thalassemia Intermedia: Results from 5-Year Long-Term Italian Multi-Center Randomized Clinical Trial

Blood (2014) 124 (21): 1354.

https://doi.org/10.1182/blood.V124.21.1354.1354

Published: 2014

Journal Articles

Prospective Comparison on Cardiac and Hepatic Iron and Cardiac Function by MR in Thalassemia Major Patients Treated with Combination Deferiprone–Desferrioxamine Versus Deferiprone and Desferrioxamine in Monoterapy,

Alessia Pepe, Antonella Meloni, PhD, Pasquale Pepe, Marcello Capra, M.D., Domenico Giuseppe D'Ascola, Michele Santodirocco, Paolo Cianciulli, M.D., Vincenzo Caruso, M.D., Maria Antonietta Romeo, M.D., Aldo Filosa, Lorella Pitrolo, Maria Caterina Putti, MD, Aurelio Maggio, MD, Massimiliano Missere, Vincenzo Positano, Massimo Lombardi, Paolo Ricchi

Blood (2011) 118 (21): 3194.

https://doi.org/10.1182/blood.V118.21.3194.3194

Published: 2011

Journal Articles

Repeated Echocardiographic Left Ventricular Ejection Fraction Measurements: A Strong and Accessible Tool for Detecting At High Risk of Heart Failure Thalassemia Major Population,

Blood (2011) 118 (21): 3197.

https://doi.org/10.1182/blood.V118.21.3197.3197

Published: 2011

Journal Articles

Diabetes Mellitus and Cardiac Complications in Thalassemia Major Patients

Maria Rita Gamberini, Antonella Meloni, PhD, Vincenzo Caruso, M.D., Marcello Capra, M.D., Paolo Cianciulli, M.D., Aurelio Maggio, MD, Elisabetta Chiodi, Massimo Lombardi, Alessia Pepe

Blood (2011) 118 (21): 2150.

https://doi.org/10.1182/blood.V118.21.2150.2150

Published: 2011

Journal Articles

Onset of Cardiac Iron Loading in a Large and Homogeneous Cohort of Thalassemia Major Paediatric Patients

Alessia Pepe, Antonella Meloni, PhD, Brunella Favilli, Marcello Capra, M.D., Domenico Giuseppe D'Ascola, Giovanni Palazzi, Antonella Quarta, M.D., Tommaso Casini, Maria Caterina Putti, MD, Paolo Cianciulli, M.D., Lucia De Franceschi, MD, Vincenzo Positano, Daniele De Marchi, Massimo Lombardi, Aldo Filosa

Blood (2011) 118 (21): 2157.

https://doi.org/10.1182/blood.V118.21.2157.2157

Published: 2011

Journal Articles

A MRI Prospective Survey on Cardiac and Hepatic Iron and Cardiac Function in Thalassemia Major Patients Treated with Sequential deferiprone–desferrioxamine versus Deferasirox

Alessia Pepe, Antonella Meloni, PhD, Giuseppe Rossi, Domenico Giuseppe D'Ascola, Marcello Capra, M.D., Aldo Filosa, Paolo Cianciulli, M.D., Luciano Prossomariti, Antonella Quarta, M.D., Tommaso Casini, Maria Grazia Bisconte, Saveria Campisi, Aurelio Maggio, MD, Cristina Salvatori, Massimo Midiri, Massimo Lombardi, Caterina Borgna-Pignatti

Blood (2011) 118 (21): 1087.

https://doi.org/10.1182/blood.V118.21.1087.1087

Published: 2011

Journal Articles

Different Patterns of Myocardial Iron Overload by T2* Cardiovascular MR As Markers of Risk for Cardiac Complication in Thalassemia Major,

Antonella Meloni, PhD, Pasquale Pepe, Petra Keilberg, Brunella Favilli, Vincenzo Positano, Marcello Capra, Vincenzo Caruso, M.D., Paolo Cianciulli, Aldo Filosa, Angelo Zuccarelli, Lucia De Franceschi, MD, Massimo Lombardi, Alessia Pepe

Blood (2011) 118 (21): 3190.

https://doi.org/10.1182/blood.V118.21.3190.3190

Published: 2011

Journal Articles

Prospective Survey on Heart and Liver Iron and Heart Function in Thalassemia Major Patients Treated with Sequential deferiprone–desferrioxamine Versus Deferiprone and Desferrioxamine in Monotherapy

Alessia Pepe, Antonella Meloni, PhD, Giuseppe Rossi, Anna Spasiano, Domenico Giuseppe D'Ascola, Aldo Filosa, Vincenzo Caruso, M.D., Paolo Cianciulli, M.D., Maria Antonietta Romeo, M.D., Maria Caterina Putti, MD, Angelo Peluso, Maria Grazia Bisconte, Maria Eliana Lai, Aurelio Maggio, MD, Cristina Salvatori, Massimo Lombardi, Marcello Capra, M.D.

Blood (2011) 118 (21): 5298.

https://doi.org/10.1182/blood.V118.21.5298.5298

Published: 2011

Journal Articles

Long-Term Use of Deferiprone Enhances Significantly the Left Ventricular Ejection Function in Thalassemia Major

Blood (2011) 118 (21): 5302.

https://doi.org/10.1182/blood.V118.21.5302.5302

Published: 2011

Journal Articles

Iron chelation with deferasirox in adult and pediatric patients with thalassemia major: efficacy and safety during 5 years' follow-up

M. Domenica Cappellini, Mohamed Bejaoui, Leyla Agaoglu, Duran Canatan, Marcello Capra, Alan Cohen, Guillermo Drelichman, Marina Economou, Slaheddine Fattoum, Antonis Kattamis, Yurdanur Kilinc, Silverio Perrotta, Antonio Piga, John B. Porter, Louis Griffel, Victor Dong, Joan Clark, Yesim Aydinok

Blood (2011) 118 (4): 884–893.

https://doi.org/10.1182/blood-2010-11-316646

Published: 2011

Includes: Supplemental data

Journal Articles

Prospective Comparison on Cardiac Iron and Liver Iron by MR In Thalassemia Major Patients Treated with Combination Deferipron–Desferrioxamine Versus Deferipron and Desferrioxamine In Monoterapy

Alessia Pepe, Giuseppe Rossi, Antonella Meloni, Dell'Amico Maria Chiara, Marcello Capra, incenzo Caruso, V, Lorella Pitrolo, MD, Michele Centra, Pasquale Pepe, Eliana Cracolici, Lucia De Franceschi, MD, Massimo Lombardi, Paolo Ricchi

Blood (2010) 116 (21): 5164.

https://doi.org/10.1182/blood.V116.21.5164.5164

Published: 2010

Journal Articles

A T2* MRI Prospective Survey on Heart and Liver Iron In Thalassemia Major Patients Treated with Sequential Deferipron–Desferrioxamine versus Deferasirox

Alessia Pepe, Giuseppe Rossi, Antonella Meloni, Dell'Amico Maria Chiara, D'Ascola Domenico Giuseppe, Marcello Capra, Aldo Filosa, Paolo Cianciulli, Aurelio Maggio, Cristina Salvatori, Gennaro Restaino, Massimo Lombardi, Caterina Borgna-Pignatti

Blood (2010) 116 (21): 5165.

https://doi.org/10.1182/blood.V116.21.5165.5165

Published: 2010

Journal Articles

A T2* MRI Prospective Survey on Heart and Liver Iron In Thalassemia Major Patients Treated with Sequential Deferiprone–Desferrioxamine versus Deferiprone and Desferrioxamine In Monotherapy

Alessia Pepe, PhD, Giuseppe Rossi, PhD, Antonella Meloni, PhD, Maria Chiara Dell'Amico, Luciano Prossomariti, PhD, Domenico Giuseppe D'Ascola, Aldo Filosa, PhD, Pasquale Pepe, PhD, Vincenzo Positano, PhD, Claudio Ascioti, Alma Lippi, MD, Massimo Lombardi, PhD, Marcello Capra, PhD

Blood (2010) 116 (21): 4259.

https://doi.org/10.1182/blood.V116.21.4259.4259

Published: 2010

Journal Articles

Myocardial Fibrosis by Delayed Enhancement Cardiovascular Magnetic Resonance and HCV Infection In Thalassemia Major Patients

Alessia Pepe, PhD, Antonella Meloni, PhD, Zelia Borsellino, PhD, Maria Chiara Dell'Amico, Caterina Borgna-Pignatti, PhD, Aurelio Maggio, Vincenzo Positano, PhD, Eliana Cracolici, PhD, Massimo Lombardi, PhD, Marcello Capra, PhD

Blood (2010) 116 (21): 4265.

https://doi.org/10.1182/blood.V116.21.4265.4265

Published: 2010

Journal Articles

A T2* MRI Prospective Survey on Heart and Liver Iron In Thalassemia Major Patients Treated with Deferasirox Versus Deferiprone and Desferrioxamine In Monotherapy

Alessia Pepe, PhD, Giuseppe Rossi, PhD, Antonella Meloni, PhD, Maria Chiara Dell'Amico, Anna Spasiano, PhD, Marcello Capra, PhD, Paolo Cianciulli, PhD, Vincenzo Caruso, PhD, Brunella Favilli, PhD, Eliana Cracolici, PhD, Massimo Lombardi, PhD, Aurelio Maggio

Blood (2010) 116 (21): 4267.

https://doi.org/10.1182/blood.V116.21.4267.4267

Published: 2010

Journal Articles

Management of chronic viral hepatitis in patients with thalassemia: recommendations from an international panel

Blood (2010) 116 (16): 2875–2883.

https://doi.org/10.1182/blood-2009-11-248724

Published: 2010

Journal Articles

Efficacy and Safety of Deferasirox (Exjade®) in Patients with β-Thalassemia Major Treated for up to 5 Years.

M. Domenica Cappellini, Silverio Perrotta, Leyla Agaoglu, Yesim Aydinok, Marcello Capra, Duran Canatan, Guillermo Drelichman, Yurdanur Kilinc, Carmelo Magnano, John B. Porter, Antonio Piga, Louis Griffel, Darlene Lagrone, Joan Clark, Antonis Kattamis

Blood (2009) 114 (22): 4063.

https://doi.org/10.1182/blood.V114.22.4063.4063

Published: 2009

Journal Articles

Comparison of Deferasirox, Deferiprone, and Desferrioxamine Effectiveness on Myocardial Iron Concentrations and Biventricular Function by Quantitative MR in Beta-Thalassemia Major

Blood (2008) 112 (11): 3872.

https://doi.org/10.1182/blood.V112.11.3872.3872

Published: 2008

Journal Articles

Multislice Multiecho T2* Cardiovascular Magnetic Resonance Detects Heterogeneous Myocardial Iron Distribution in Thalassemia Patients

Vincenzo Positano, MSc, Alessia Pepe, MD, PhD, Anna Ramazzotti, PhD, Maria Filomena Santarelli, PhD, Antonella Meloni, MSc, Anna Spasiano, MD, Caterina Borgna-Pignatti, MD, Paolo Cianciulli, MD, Marcello Capra, MD, Maria-Eliana Lai, MD, Aurelio Maggio, MD, Massimo Lombardi, MD, Luigi Landini, PhD

Blood (2008) 112 (11): 3877.

https://doi.org/10.1182/blood.V112.11.3877.3877

Published: 2008

Journal Articles

Cardiac and Liver Magnetic Resonance Characterization of Thalassemia Intermedia Patients: A Comparative Multicenter Study Versus Thalassemia Major Patients

Alessia Pepe, MD, PhD, Brunella Favilli, MSc, Anna Ramazzotti, PhD, Vincenzo Positano, MSc, Caterina Borgna-Pignatti, MD, Marcello Capra, MD, Maria-Eliana Lai, MD, Anna Spasiano, MD, Lorella Pitrolo, MD, Aldo Filosa, MD, Paolo Cianciulli, MD, Antonietta Mascolino, MD, Gaetano Giuffrida, MD, Gianluca Forni, MD, Aurelio Maggio, MD, Massimo Lombardi

Blood (2008) 112 (11): 5421.

https://doi.org/10.1182/blood.V112.11.5421.5421

Published: 2008

NARROW

Deferiprone Versus Deferoxamine in Thalassemia Intermedia: Results from 5-Year Long-Term Italian Multi-Center Randomized Clinical Trial

Prospective Comparison on Cardiac and Hepatic Iron and Cardiac Function by MR in Thalassemia Major Patients Treated with Combination Deferiprone–Desferrioxamine Versus Deferiprone and Desferrioxamine in Monoterapy,

Repeated Echocardiographic Left Ventricular Ejection Fraction Measurements: A Strong and Accessible Tool for Detecting At High Risk of Heart Failure Thalassemia Major Population,

Diabetes Mellitus and Cardiac Complications in Thalassemia Major Patients

Onset of Cardiac Iron Loading in a Large and Homogeneous Cohort of Thalassemia Major Paediatric Patients

A MRI Prospective Survey on Cardiac and Hepatic Iron and Cardiac Function in Thalassemia Major Patients Treated with Sequential deferiprone–desferrioxamine versus Deferasirox

Different Patterns of Myocardial Iron Overload by T2* Cardiovascular MR As Markers of Risk for Cardiac Complication in Thalassemia Major,

Prospective Survey on Heart and Liver Iron and Heart Function in Thalassemia Major Patients Treated with Sequential deferiprone–desferrioxamine Versus Deferiprone and Desferrioxamine in Monotherapy

Long-Term Use of Deferiprone Enhances Significantly the Left Ventricular Ejection Function in Thalassemia Major

Iron chelation with deferasirox in adult and pediatric patients with thalassemia major: efficacy and safety during 5 years' follow-up

Prospective Comparison on Cardiac Iron and Liver Iron by MR In Thalassemia Major Patients Treated with Combination Deferipron–Desferrioxamine Versus Deferipron and Desferrioxamine In Monoterapy

A T2* MRI Prospective Survey on Heart and Liver Iron In Thalassemia Major Patients Treated with Sequential Deferipron–Desferrioxamine versus Deferasirox

A T2* MRI Prospective Survey on Heart and Liver Iron In Thalassemia Major Patients Treated with Sequential Deferiprone–Desferrioxamine versus Deferiprone and Desferrioxamine In Monotherapy

Myocardial Fibrosis by Delayed Enhancement Cardiovascular Magnetic Resonance and HCV Infection In Thalassemia Major Patients

A T2* MRI Prospective Survey on Heart and Liver Iron In Thalassemia Major Patients Treated with Deferasirox Versus Deferiprone and Desferrioxamine In Monotherapy

Management of chronic viral hepatitis in patients with thalassemia: recommendations from an international panel

Efficacy and Safety of Deferasirox (Exjade®) in Patients with β-Thalassemia Major Treated for up to 5 Years.

Comparison of Deferasirox, Deferiprone, and Desferrioxamine Effectiveness on Myocardial Iron Concentrations and Biventricular Function by Quantitative MR in Beta-Thalassemia Major

Multislice Multiecho T2* Cardiovascular Magnetic Resonance Detects Heterogeneous Myocardial Iron Distribution in Thalassemia Patients

Cardiac and Liver Magnetic Resonance Characterization of Thalassemia Intermedia Patients: A Comparative Multicenter Study Versus Thalassemia Major Patients

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only